Sullivan Christopher Ryan Insider Trades & Stock Holdings

Chief Financial Officer · Avalo Therapeutics, Inc. · Latest filing Sep 16, 2026

Sullivan Christopher Ryan, Chief Financial Officer at Avalo Therapeutics, Inc. has 1 Form 4 trade on file since Sep 16, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($202.44K), net -$202.44K. Latest filing: disposed of 12.39K shares of $AVTX on Sep 16, 2026 at $16.33.

Trades on file

1

Open-market bought

$0

Open-market sold

$202.44K

Net open-market

-$202.44K

Latest filing

Sep 16, 2026

All insider trades by Sullivan Christopher Ryan

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Sep 16, 2026	$AVTX	Sell (Open-market sale) 10b5-1	12.39K	$16.33	$202.44K			-7.7%	-32.0%		Chief Financial Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Sullivan Christopher Ryan traded

• $AVTX

Frequently asked questions

Has Sullivan Christopher Ryan been buying or selling stock?

Sullivan Christopher Ryan has 0 open-market purchases and 1 open-market sale on file, net -$202.44K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Sullivan Christopher Ryan's latest insider trade?

disposed of 12.39K shares of $AVTX on Sep 16, 2026 at $16.33.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.